Lysine 63-linked ubiquitination of tau oligomers contributes to the pathogenesis of Alzheimer’s disease

MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification

Cox, J., & Mann, M. (2008) · Nature Biotechnology · doi:10.1038/nbt.1511 · Cited by 14,855 · see citing works

2021 Alzheimer's disease facts and figures

Anonymous (2021) · Alzheimer s & Dementia · doi:10.1002/alz.12328 · Cited by 2,236 · see citing works

Ubiquitin modifications

Swatek, K. N., & Komander, D. (2016) · Cell Research · doi:10.1038/cr.2016.39 · Cited by 2,070 · see citing works

Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects

Shaw, L. M., Vanderstichele, H., Knapik‐Czajka, M., Clark, C. M., Aisen, P. S., Petersen, R. C., Blennow, K., Soares, H., Simon, A., Lewczuk, P., et al. (2009) · Annals of Neurology · doi:10.1002/ana.21610 · Cited by 2,065 · see citing works

Proteasome-Independent Functions of Ubiquitin in Endocytosis and Signaling

Mukhopadhyay, D., & Riezman, H. (2007) · Science · doi:10.1126/science.1127085 · Cited by 1,221 · see citing works

Ubiquitin Is a Component of Paired Helical Filaments in Alzheimer's Disease

Mori, H., Kondo, J., & Ihara, Y. (1987) · Science · doi:10.1126/science.3029875 · Cited by 843 · see citing works

CHIP and Hsp70 regulate tau ubiquitination, degradation and aggregation

Petrucelli, L. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh083 · Cited by 735 · see citing works

The acetylation of tau inhibits its function and promotes pathological tau aggregation

Cohen, T. J., Guo, J. L., Hurtado, D. E., Kwong, L. K., Mills, I. P., Trojanowski, J. Q., & Lee, V. M. Y. (2011) · Nature Communications · doi:10.1038/ncomms1255 · Cited by 724 · see citing works

Proteopathic tau seeding predicts tauopathy in vivo

Holmes, B. B., Furman, J. L., Mahan, T. E., Yamasaki, T. R., Mirbaha, H., Eades, W. C., Belaygorod, L., Cairns, N. J., Holtzman, D. M., & Diamond, M. I. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1411649111 · Cited by 696 · see citing works

The mystery of BCL2 family: Bcl-2 proteins and apoptosis: an update

Siddiqui, W. A., Ahad, A., & Ahsan, H. (2015) · Archives of Toxicology · doi:10.1007/s00204-014-1448-7 · Cited by 689 · see citing works

The release and trans-synaptic transmission of Tau via exosomes

Wang, Y., Balaji, V., Kaniyappan, S., Krüger, L., Irsen, S., Tepper, K., Chandupatla, R., Maetzler, W., Schneider, A., Mandelkow, E., et al. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-016-0143-y · Cited by 674 · see citing works

A First Line of Stress Defense: Small Heat Shock Proteins and Their Function in Protein Homeostasis

Haslbeck, M., & Vierling, E. (2015) · Journal of Molecular Biology · doi:10.1016/j.jmb.2015.02.002 · Cited by 633 · see citing works

Propagation of Tau aggregates and neurodegeneration

Goedert, M., Eisenberg, D. S., & Crowther, R. A. (2017) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-072116-031153 · Cited by 632 · see citing works

ApoE and Aβ in Alzheimer’s Disease: Accidental Encounters or Partners?

Kanekiyo, T., Xu, H., & Bu, G. (2014) · Neuron · doi:10.1016/j.neuron.2014.01.045 · Cited by 608 · see citing works

Novel tau filament fold in corticobasal degeneration

Zhang, W., Tarutani, A., Newell, K. L., Murzin, A. G., Matsubara, T., Falcon, B., Vidal, R., Garringer, H. J., Shi, Y., Ikeuchi, T., et al. (2020) · Nature · doi:10.1038/s41586-020-2043-0 · Cited by 546 · see citing works

Identification of oligomers at early stages of tau aggregation in Alzheimer's disease

Lasagna‐Reeves, C. A., Castillo‐Carranza, D. L., Sengupta, U., Sarmiento, J., Troncoso, J., Jackson, G. R., & Kayed, R. (2012) · The FASEB Journal · doi:10.1096/fj.11-199851 · Cited by 527 · see citing works

Accumulation of Pathological Tau Species and Memory Loss in a Conditional Model of Tauopathy

Berger, Z., Roder, H. M., Hanna, A., Carlson, A. M., Rangachari, V., Yue, M., Wszołek, Z. K., Ashe, K. H., Knight, J. A., Dickson, D. W., et al. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.0587-07.2007 · Cited by 485 · see citing works

A Multi-network Approach Identifies Protein-Specific Co-expression in Asymptomatic and Symptomatic Alzheimer’s Disease

Seyfried, N. T., Dammer, E. B., Swarup, V., Nandakumar, D., Duong, D. M., Yin, L., Deng, Q., Nguyen, T., Hales, C. M., Wingo, T., et al. (2017) · Cell Systems · doi:10.1016/j.cels.2016.11.006 · Cited by 477 · see citing works

A current view on Tau protein phosphorylation in Alzheimer's disease

Wegmann, S., Biernat, J., & Mandelkow�, E. (2021) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2021.03.003 · Cited by 464 · see citing works

Tau-driven 26S proteasome impairment and cognitive dysfunction can be prevented early in disease by activating cAMP-PKA signaling

Myeku, N., Clelland, C. L., Emrani, S., Kukushkin, N. V., Yu, W. H., Goldberg, A. L., & Duff, K. E. (2016) · Nature Medicine · doi:10.1038/nm.4011 · Cited by 446 · see citing works

Lysine 63-linked ubiquitination promotes the formation and autophagic clearance of protein inclusions associated with neurodegenerative diseases

Tan, J. M. M., Wong, E. S. P., Kirkpatrick, D. S., Pletniková, O., Ko, H. S., Tay, S.-P., Ho, M. W. L., Troncoso, J. C., Gygi, S. P., Lee, M. K., et al. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm320 · Cited by 444 · see citing works

Tau molecular diversity contributes to clinical heterogeneity in Alzheimer’s disease

Dujardin, S., Commins, C., Lathuiliere, A., Beerepoot, P., Fernandes, A. R., Kamath, T. V., De Los Santos, M. B., Klickstein, N., Corjuc, D. L., Corjuc, B. T., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0938-9 · Cited by 438 · see citing works

Tau association with synaptic vesicles causes presynaptic dysfunction

Zhou, L., McInnes, J., Wierda, K., Holt, M., Herrmann, A. G., Jackson, R. J., Wang, Y.-C., Swerts, J., Beyens, J., Miskiewicz, K., et al. (2017) · Nature Communications · doi:10.1038/ncomms15295 · Cited by 434 · see citing works

Crosstalk Between Mammalian Autophagy and the Ubiquitin-Proteasome System

Kocatürk, N. M., & Gözüaçık, D. (2018) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2018.00128 · Cited by 415 · see citing works

Posttranslational Modifications Mediate the Structural Diversity of Tauopathy Strains

Arakhamia, T., Lee, C. E., Carlomagno, Y., Kumar, M., Duong, D. M., Wesseling, H., Kundinger, S. R., Wang, K., Williams, D., Deture, M. A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.01.027 · Cited by 400 · see citing works

Neurons May Live for Decades with Neurofibrillary Tangles

Morsch, R., Simon, W., & Coleman, P. D. (1999) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199902000-00008 · Cited by 370 · see citing works

Tau Post-translational Modifications: Dynamic Transformers of Tau Function, Degradation, and Aggregation

Alquezar, C., Arya, S., & Kao, A. W. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2020.595532 · Cited by 367 · see citing works

Tau degradation: The ubiquitin–proteasome system versus the autophagy-lysosome system

Lee, M. J., Lee, J. H., & Rubinsztein, D. C. (2013) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.03.001 · Cited by 364 · see citing works

Preparation and Characterization of Neurotoxic Tau Oligomers

Lasagna-Reeves, C. A., Castillo-Carranza, D. L., Guerrero-Muñoz, M. J., Jackson, G. R., & Kayed, R. (2010) · Biochemistry · doi:10.1021/bi1016233 · Cited by 359 · see citing works

A common mechanism of proteasome impairment by neurodegenerative disease-associated oligomers

Thibaudeau, T. A., Anderson, R. T., & Smith, D. M. (2018) · Nature Communications · doi:10.1038/s41467-018-03509-0 · Cited by 356 · see citing works

Ubiquitin is conjugated with amino-terminally processed tau in paired helical filaments

Morishima-Kawashima, M., Hasegawa, M., Takio, K., Suzuki, M., Titani, K., & Ihara, Y. (1993) · Neuron · doi:10.1016/0896-6273(93)90063-w · Cited by 332 · see citing works

Sequestosome 1/p62 shuttles polyubiquitinated tau for proteasomal degradation

Babu, J. R., Geetha, T., & Wooten, M. W. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03181.x · Cited by 315 · see citing works

Alzheimer Disease-specific Conformation of Hyperphosphorylated Paired Helical Filament-Tau Is Polyubiquitinated through Lys-48, Lys-11, and Lys-6 Ubiquitin Conjugation

Cripps, D., Thomas, S. N., Jeng, Y., Yang, F., Davies, P., & Yang, A. J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m512786200 · Cited by 312 · see citing works

Endoplasmic reticulum stress and inflammation in the central nervous system

Sprenkle, N. T., Sims, S. G., Sánchez, C. L., & Meares, G. P. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0183-y · Cited by 299 · see citing works

Alzheimer Disease Pathogenesis: Insights From Molecular and Cellular Biology Studies of Oligomeric Aβ and Tau Species

Chen, X., & Mobley, W. C. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00659 · Cited by 291 · see citing works

Passive Immunization with Tau Oligomer Monoclonal Antibody Reverses Tauopathy Phenotypes without Affecting Hyperphosphorylated Neurofibrillary Tangles

Castillo-Carranza, D. L., Sengupta, U., Guerrero-Muñoz, M. J., Lasagna-Reeves, C. A., Gerson, J. E., Singh, G., Estes, D. M., Barrett, A. D. T., Dineley, K. T., Jackson, G. R., et al. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.3192-13.2014 · Cited by 278 · cited 1× · see citing works

Template-assisted filament growth by parallel stacking of tau

Margittai, M., & Langen, R. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401911101 · Cited by 276 · see citing works

Tau Accumulation Activates the Unfolded Protein Response by Impairing Endoplasmic Reticulum-Associated Degradation

Abisambra, J. F., Jinwal, U. K., Blair, L. J., O’Leary, J. C., Li, Q., Brady, S., Wang, L., Guidi, C., Zhang, B., Nordhues, B. A., et al. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.5397-12.2013 · Cited by 268 · see citing works

Why do cellular proteins linked to K63‐polyubiquitin chains not associate with proteasomes?

Nathan, J. A., Kim, H. T., Ting, L., Gygi, S. P., & Goldberg, A. L. (2013) · The EMBO Journal · doi:10.1038/emboj.2012.354 · Cited by 253 · see citing works

Internalized Tau Oligomers Cause Neurodegeneration by Inducing Accumulation of Pathogenic Tau in Human Neurons Derived from Induced Pluripotent Stem Cells

Usenovic, M., Niroomand, S., Drolet, R. E., Yao, L., Gaspar, R. C., Hatcher, N. G., Schachter, J., Renger, J. J., & Parmentier-Batteur, S. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.1523-15.2015 · Cited by 245 · see citing works

Understanding the role of histone deacetylase and their inhibitors in neurodegenerative disorders: current targets and future perspective

Kumar, V., Kundu, S., Singh, A., & Singh, S. (2022) · Current Neuropharmacology · doi:10.2174/1570159x19666210609160017 · Cited by 210 · see citing works

Biochemical classification of tauopathies by immunoblot, protein sequence and mass spectrometric analyses of sarkosyl-insoluble and trypsin-resistant tau

Taniguchi-Watanabe, S., Arai, T., Kametani, F., Nonaka, T., Masuda-Suzukake, M., Tarutani, A., Murayama, S., Saito, Y., Arima, K., Yoshida, M., et al. (2016) · Acta Neuropathologica · doi:10.1007/s00401-015-1503-3 · Cited by 200 · see citing works

Intracellular Trafficking of Histone Deacetylase 4 Regulates Neuronal Cell Death

Bolger, T. A., & Yao, T. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.1826-05.2005 · Cited by 190 · see citing works

Epidermal growth factor receptor is a preferred target for treating Amyloid-β–induced memory loss

Wang, L., Chiang, H.-C., Wu, W., Liang, B., Xie, Z., Yao, X., Ma, W., Du, S., & Zhong, Y. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1208011109 · Cited by 190 · see citing works

The Ubiquitin-Proteasome System and the Autophagic-Lysosomal System in Alzheimer Disease

Ihara, Y., Morishima-Kawashima, M., & Nixon, R. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006361 · Cited by 190 · see citing works

Acetylation Disfavors Tau Phase Separation

Ferreon, J. C., Jain, A., Choi, K.-J., Tsoi, P. S., MacKenzie, K. R., Jung, S. Y., & Ferreon, A. C. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19051360 · Cited by 183 · see citing works

Regional protein expression in human Alzheimer’s brain correlates with disease severity

Xu, J., Patassini, S., Rustogi, N., Riba‐Garcia, I., Hale, B. D., Phillips, A. M., Waldvogel, H. J., Haines, R., Bradbury, P., Stevens, A., et al. (2019) · Communications Biology · doi:10.1038/s42003-018-0254-9 · Cited by 182 · see citing works

Specific Targeting of Tau Oligomers in Htau Mice Prevents Cognitive Impairment and Tau Toxicity Following Injection with Brain-Derived Tau Oligomeric Seeds

Castillo‐Carranza, D. L., Gerson, J. E., Sengupta, U., Guerrero‐Munoz, M. J., Lasagna‐Reeves, C. A., & Kayed, R. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-132477 · Cited by 180 · see citing works

CSF tau microtubule binding region identifies tau tangle and clinical stages of Alzheimer’s disease

Horie, K., Barthélemy, N. R., Sato, C., & Bateman, R. J. (2021) · Brain · doi:10.1093/brain/awaa373 · Cited by 180 · see citing works

Prevention of tau seeding and propagation by immunotherapy with a central tau epitope antibody

Albert, M., Mairet‐Coello, G., Danis, C., Lieger, S., Caillierez, R., Carrier, S., Skrobala, E., Landrieu, I., Michel, A., Schmitt, M., et al. (2019) · Brain · doi:10.1093/brain/awz100 · Cited by 177 · see citing works

Tau Oligomers Associate with Inflammation in the Brain and Retina of Tauopathy Mice and in Neurodegenerative Diseases

Nilson, A. N., English, K. C., Gerson, J. E., Whittle, T. B., Crain, C. N., Xue, J. J., Sengupta, U., Castillo‐Carranza, D. L., Zhang, W., Gupta, P. K., et al. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160912 · Cited by 170 · see citing works

Targeting Autophagy for the Treatment of Alzheimer’s Disease: Challenges and Opportunities

Liu, J., & Li, L. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00203 · Cited by 159 · see citing works

Prolonged tau clearance and stress vulnerability rescue by pharmacological activation of autophagy in tauopathy neurons

Silva, M. C., Nandi, G. A., Tentarelli, S., Gurrell, I. K., Jamier, T., Lucente, D., Dickerson, B. C., Brown, D. G., Brandon, N. J., & Haggarty, S. J. (2020) · Nature Communications · doi:10.1038/s41467-020-16984-1 · Cited by 157 · see citing works

Assessment of CSF levels of tau protein in mildly demented patients with Alzheimer's disease

Galasko, D. R., Clark, C., Chang, L., Miller, B. L., Green, R. C., Motter, R. N., & Seubert, P. A. (1997) · Neurology · doi:10.1212/wnl.48.3.632 · Cited by 153 · see citing works

Soluble pre-fibrillar tau and β-amyloid species emerge in early human Alzheimer’s disease and track disease progression and cognitive decline

Koss, D. J., Jones, G., Cranston, A., Gardner, H., Kanaan, N. M., & Platt, B. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1632-3 · Cited by 149 · see citing works

Rapid Progression from Mild Cognitive Impairment to Alzheimer’s Disease in Subjects with Elevated Levels of Tau in Cerebrospinal Fluid and the APOE ε4/ε4 Genotype

Blom, E. S., Giedraitis, V., Zetterberg, H., Fukumoto, H., Blennow, K., Hyman, B. T., Irizarry, M. C., Wahlund, L., Lannfelt, L., & Ingelsson, M. (2009) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000216841 · Cited by 141 · see citing works

Lysine-Directed Post-translational Modifications of Tau Protein in Alzheimer's Disease and Related Tauopathies

Kontaxi, C., Piccardo, P., & Gill, A. C. (2017) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2017.00056 · Cited by 138 · see citing works

Amyloid-β Annular Protofibrils Evade Fibrillar Fate in Alzheimer Disease Brain

Lasagna‐Reeves, C. A., Glabe, C. G., & Kayed, R. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.236257 · Cited by 136 · see citing works

Pre-clinical characterisation of E2814, a high-affinity antibody targeting the microtubule-binding repeat domain of tau for passive immunotherapy in Alzheimer’s disease

Roberts, M., Sevastou, I., Imaizumi, Y., Mistry, K., Talma, S., Dey, M., Gartlon, J., Ochiai, H., Zhou, Z., Akasofu, S., et al. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-0884-2 · Cited by 135 · see citing works

A Role for Calcineurin in Alzheimers Disease

Reese, L. C., & Taglialatela, G. (2011) · Current Neuropharmacology · doi:10.2174/157015911798376316 · Cited by 131 · see citing works

P53 aggregation, interactions with tau, and impaired DNA damage response in Alzheimer’s disease

Farmer, K. M., Ghag, G., Puangmalai, N., Montalbano, M., Bhatt, N. N., & Kayed, R. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-01012-6 · Cited by 126 · see citing works

Evidence that Non-Fibrillar Tau Causes Pathology Linked to Neurodegeneration and Behavioral Impairments

Brunden, K. R., Trojanowski, J. Q., & Lee, V. M. ‐. (2008) · Journal of Alzheimer s Disease · doi:10.3233/jad-2008-14406 · Cited by 125 · see citing works

Brain site-specific proteome changes in aging-related dementia

Manavalan, A., Mishra, M., Feng, L., Sze, S. K., Akatsu, H., & Heese, K. (2013) · Experimental & Molecular Medicine · doi:10.1038/emm.2013.76 · Cited by 114 · see citing works

Promoting tau secretion and propagation by hyperactive p300/CBP via autophagy-lysosomal pathway in tauopathy

Chen, X., Li, Y., Wang, C., Tang, Y., Mok, S., Tsai, R. M., Rojas, J. C., Karydas, A., Miller, B. L., Boxer, A. L., et al. (2020) · Molecular Neurodegeneration · doi:10.1186/s13024-019-0354-0 · Cited by 113 · see citing works

HDAC4 as a potential therapeutic target in neurodegenerative diseases: a summary of recent achievements

Mielcarek, M., Zielonka, D., Carnemolla, A., Marcinkowski, T., & Guidez, F. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00042 · Cited by 111 · see citing works

A Dual Pathogenic Mechanism Links Tau Acetylation to Sporadic Tauopathy

Trzeciakiewicz, H., Tseng, J., Wander, C. M., Madden, V. J., Tripathy, A., Yuan, C., & Cohen, T. J. (2017) · Scientific Reports · doi:10.1038/srep44102 · Cited by 110 · see citing works

Internalization mechanisms of brain-derived tau oligomers from patients with Alzheimer’s disease, progressive supranuclear palsy and dementia with Lewy bodies

Puangmalai, N., Bhatt, N. N., Montalbano, M., Sengupta, U., Gaikwad, S., Ventura, F. L., McAllen, S., Ellsworth, A., García, S., & Kayed, R. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2503-3 · Cited by 110 · see citing works

Mechanically induced development and maturation of human intestinal organoids in vivo

Poling, H. M., Wu, D. X.-Y., Brown, N. E., Baker, M. L., Hausfeld, T. A., Huynh, N., Chaffron, S., Dunn, J., Hogan, S. P., Wells, J. M., et al. (2018) · Nature Biomedical Engineering · doi:10.1038/s41551-018-0243-9 · Cited by 107 · see citing works

Inhibition of Bax protects neuronal cells from oligomeric Aβ neurotoxicity

Kudo, W., Hp, L., Smith, M. A., Zhu, X., Matsuyama, S., & Lee, H.-G. (2012) · Cell Death and Disease · doi:10.1038/cddis.2012.43 · Cited by 104 · see citing works

Pathological Changes of Tau Related to Alzheimer’s Disease

Chu, D., & Liu, F. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00457 · Cited by 103 · see citing works

Quantitative Analysis of the Brain Ubiquitylome in Alzheimer's Disease

Abreha, M. H., Dammer, E. B., Ping, L., Zhang, T., Duong, D. M., Gearing, M., Lah, J. J., Levey, A. I., & Seyfried, N. T. (2018) · PROTEOMICS · doi:10.1002/pmic.201800108 · Cited by 81 · see citing works

Tangle-Bearing Neurons Survive Despite Disruption of Membrane Integrity in a Mouse Model of Tauopathy

de Calignon, A., Spires-Jones, T. L., Pitstick, R., Carlson, G. A., & Hyman, B. T. (2009) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181a9fc66 · Cited by 81 · see citing works

Tau oligomers in cerebrospinal fluid in Alzheimer's disease

Sengupta, U., Portelius, E., Hansson, O., Farmer, K., Castillo‐Carranza, D., Woltjer, R., Zetterberg, H., Galasko, D., Blennow, K., & Kayed, R. (2017) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.382 · Cited by 77 · see citing works

The Ubiquitin System in Alzheimer’s Disease

Harris, L. D., Jasem, S., & Licchesi, J. D. F. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-38266-7_8 · Cited by 76 · see citing works

Ubiquitin Signaling and Degradation of Aggregate-Prone Proteins

Galves, M., Rathi, R., Prag, G., & Ashkenazi, A. (2019) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2019.04.007 · Cited by 73 · see citing works

Neurofibrillary Tangles May Interfere With Smad 2/3 Signaling in Neurons

Chalmers, K. A., & Love, S. (2007) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3180303b93 · Cited by 66 · see citing works

Applications of selected reaction monitoring (SRM)-mass spectrometry (MS) for quantitative measurement of signaling pathways

Zhao, Y., & Brasier, A. R. (2013) · Methods · doi:10.1016/j.ymeth.2013.02.001 · Cited by 56 · see citing works

HDAC4 protects cells from ER stress induced apoptosis through interaction with ATF4

Zhang, P., Sun, Q., Zhao, C., Ling, S., Li, Q., Chang, Y.-Z., & Li, Y. (2014) · Cellular Signalling · doi:10.1016/j.cellsig.2013.11.026 · Cited by 54 · see citing works

Aberrant Expression of Histone Deacetylases 4 in Cognitive Disorders: Molecular Mechanisms and a Potential Target

Wu, Y., Hou, F., Wang, X., Kong, Q., Han, X., & Bai, B. (2016) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2016.00114 · Cited by 52 · see citing works

Hippocampal tau oligomerization early in tau pathology coincides with a transient alteration of mitochondrial homeostasis and DNA repair in a mouse model of tauopathy

Zheng, J., Akbari, M., Schirmer, C., Reynaert, M., Loyens, A., Lefebvre, B., Buée, L., Croteau, D. L., Galas, M., & Bohr, V. A. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-00896-8 · Cited by 51 · see citing works

Modulating disease-relevant tau oligomeric strains by small molecules

Cascio, F. L., García, S., Montalbano, M., Puangmalai, N., McAllen, S., Pace, A., Piccionello, A. P., & Kayed, R. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.014630 · Cited by 51 · see citing works

Knockin’ on heaven’s door: Molecular mechanisms of neuronal tau uptake

La‐Rocque, S. D., Moretto, E., Butnaru, I., & Schiavo, G. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.15144 · Cited by 42 · see citing works

Immunoreactivity to Lys63-linked polyubiquitin is a feature of neurodegeneration

Paine, S., Bedford, L., Thorpe, J. R., Mayer, R. J., Cavey, J. R., Bajaj, N., Sheppard, P. W., Lowe, J., & Layfield, R. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.05.074 · Cited by 41 · see citing works

Photoactivation of TGFβ/SMAD signaling pathway ameliorates adult hippocampal neurogenesis in Alzheimer’s disease model

Wu, X., Shen, Q., Zhang, Z., Zhang, D., Gu, Y., & Xing, D. (2021) · Stem Cell Research & Therapy · doi:10.1186/s13287-021-02399-2 · Cited by 40 · see citing works

Crystal structure of a conformational antibody that binds tau oligomers and inhibits pathological seeding by extracts from donors with Alzheimer's disease

Abskharon, R. N. N., Seidler, P. M., Sawaya, M. R., Cascio, D., Yang, T. P., Philipp, S., Williams, C. K., Newell, K. L., Ghetti, B. F., Deture, M. A., et al. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.013638 · Cited by 31 · see citing works

Tau hyperphosphorylation affects Smad 2/3 translocation

Baig, S., Helmond, Z. V., & Love, S. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.06.045 · Cited by 30 · see citing works

Cellular Models for the Study of PrionsPreprint

Holmes, B. B., & Diamond, M. I. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a024026 · Cited by 22 · see citing works

The Impact of EGFR Gene Polymorphisms on the Risk of Alzheimer’s Disease in a Chinese Han Population: A Case-Controlled Study

Chen, X., Wang, C., Zhou, S., Li, X., & Wu, L. (2018) · Medical Science Monitor · doi:10.12659/msm.907809 · Cited by 21 · see citing works

Severe oligomeric tau toxicity can be reversed without long-term sequelae

Martinisi, A., Flach, M., Sprenger, F., Frank, S., Tolnay, M., & Winkler, D. T. (2020) · Brain · doi:10.1093/brain/awaa445 · Cited by 20 · see citing works

Proteasome Assay in Cell Lysates

Maher, P. A. (2014) · BIO-PROTOCOL · doi:10.21769/bioprotoc.1028 · Cited by 15 · see citing works

Novel Peptidomic Approach for Identification of Low and High Molecular Weight Tauopathy Peptides Following Calpain Digestion, and Primary Culture Neurotoxic Challenges

Yadikar, H., Johnson, C., Pafundi, N., Mouhawasse, E., Nguyen, L. T., Torres, I., Kurup, M., Yang, Z., Kobeissy, F. H., Yost, R. A., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20205213 · Cited by 12 · see citing works

Cellular and pathological functions of tau

Bravo, C. P., Naguib, S. A., & Gan, L. (2024) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-024-00753-9 · Cited by 245 · see citing works

Type 2 Diabetes Mellitus and Alzheimer’s Disease: Shared Molecular Mechanisms and Potential Common Therapeutic Targets

Hamzé, R., Delangre, E., Tolu, S., Moreau, M., Janel, N., Bailbé, D., & Movassat, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232315287 · Cited by 163 · see citing works

X-linked ubiquitin-specific peptidase 11 increases tauopathy vulnerability in women

Yan, Y., Wang, X., Chaput, D., Shin, M.-K., Koh, Y., Gan, L., Pieper, A. A., Woo, J.-A. A., & Kang, D. E. (2022) · Cell · doi:10.1016/j.cell.2022.09.002 · Cited by 144 · see citing works

Modeling late-onset Alzheimer’s disease neuropathology via direct neuronal reprogramming

Sun, Z., Kwon, J.-S., Ren, Y., Chen, S., Walker, C. K., Lu, X., Cates, K., Karahan, H., Sviben, S., Fitzpatrick, J. A. J., et al. (2024) · Science · doi:10.1126/science.adl2992 · Cited by 77 · see citing works

Targeting tau in Alzheimer's disease: from mechanisms to clinical therapy

Ye, J., Wan, H., Chen, S., & Liu, G. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.385847 · Cited by 69 · see citing works

Protein aggregation and its affecting mechanisms in neurodegenerative diseases

Wu, J., Wu, J., Chen, T., Cai, J., & Ren, R. (2024) · Neurochemistry International · doi:10.1016/j.neuint.2024.105880 · Cited by 61 · see citing works

Nasal tau immunotherapy clears intracellular tau pathology and improves cognitive functions in aged tauopathy mice

Gaikwad, S., Puangmalai, N., Sonawane, M., Montalbano, M., Price, R., Iyer, M. S., Ray, A., Moreno, S., & Kayed, R. (2024) · Science Translational Medicine · doi:10.1126/scitranslmed.adj5958 · Cited by 46 · see citing works

Tau degradation in Alzheimer's disease: Mechanisms and therapeutic opportunities

Wang, L., Banesh, S., Kumar, R., Schedin‐Weiss, S., Tjernberg, L. O., & Winblad, B. G. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70048 · Cited by 45 · see citing works

In pursuit of degenerative brain disease diagnosis: Dementia biomarkers detected by DNA aptamer-attached portable graphene biosensor

Bodily, T. A., Ramanathan, A., Wei, S., Karkisaval, A. G., Bhatt, N. N., Jerez, C., Haque, M. A., Ramil, A., Heda, P., Wang, Y., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2311565120 · Cited by 37 · see citing works

Phosphorylation of tau at a single residue inhibits binding to the E3 ubiquitin ligase, CHIP

Nadel, C. M., Pokhrel, S., Wucherer, K., Oehler, A., Thwin, A. C., Basu, K., Callahan, M. D., Southworth, D. R., Mordes, D. A., Craik, C. S., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-52075-1 · Cited by 36 · see citing works

Aggregation, Transmission, and Toxicity of the Microtubule-Associated Protein Tau: A Complex Comprehension

Hu, J., Sha, W., Yuan, S., Wu, J., & Huang, Y. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241915023 · Cited by 35 · see citing works

Brain-derived tau oligomer polymorphs: distinct aggregations, stability profiles, and biological activities

Cascio, F. L., Park, S., Sengupta, U., Puangmalai, N., Bhatt, N. N., Shchankin, N., Jerez, C., Moreno, N., Bittar, A., Xavier, R., et al. (2025) · Communications Biology · doi:10.1038/s42003-025-07499-w · Cited by 35 · see citing works

The autophagy adaptor TRIAD3A promotes tau fibrillation by nested phase separation

Zhou, J., Chuang, Y. ‘., Redding‐Ochoa, J., Zhang, R., Platero, A. J., Barrett, A., Troncoso, J. C., Worley, P. F., & Zhang, W. (2024) · Nature Cell Biology · doi:10.1038/s41556-024-01461-4 · Cited by 33 · see citing works

Complicated Role of Post-translational Modification and Protease-Cleaved Fragments of Tau in Alzheimer’s Disease and Other Tauopathies

Yang, J., Shen, N., Shen, J., Yang, Y., & Li, H.-L. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03867-x · Cited by 32 · see citing works

Post-Translational Modifications in Tau and Their Roles in Alzheimer's Pathology

Kalyaanamoorthy, S., Opare, S. K. A., Xu, X., Ganesan, A., & Rao, P. P. N. (2024) · Current Alzheimer Research · doi:10.2174/0115672050301407240408033046 · Cited by 31 · see citing works

Flanking regions, amyloid cores, and polymorphism: the potential interplay underlying structural diversity

Bhopatkar, A. A., & Kayed, R. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.105122 · Cited by 27 · see citing works

Amyloid-β oligomers increase the binding and internalization of tau oligomers in human synapses

Kadamangudi, S., Marcatti, M., Zhang, W.-R., Fracassi, A., Kayed, R., Limon, A., & Taglialatela, G. (2024) · Acta Neuropathologica · doi:10.1007/s00401-024-02839-2 · Cited by 25 · see citing works

The Mechanistic Link Between Tau-Driven Proteotoxic Stress and Cellular Senescence in Alzheimer’s Disease

Tangavelou, K., & Bhaskar, K. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252212335 · Cited by 24 · see citing works

Distinct neurotoxic TDP-43 fibril polymorphs are generated by heterotypic interactions with α-Synuclein

Dhakal, S., Robang, A. S., Bhatt, N. N., Puangmalai, N., Fung, L., Kayed, R., Paravastu, A. K., & Rangachari, V. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.102498 · Cited by 23 · see citing works

Potential Mechanisms of Tunneling Nanotube Formation and Their Role in Pathology Spread in Alzheimer’s Disease and Other Proteinopathies

Kotarba, S., Kozłowska, M., Scios, M., Saramowicz, K., Barczuk, J., Granek, Z., Siwecka, N., Wiese, W., Golberg, M., Galita, G., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251910797 · Cited by 21 · see citing works

Alzheimer proteopathic tau seeds are biochemically a forme fruste of mature paired helical filaments

Kumar, M., Quittot, N., Dujardin, S., Schlaffner, C. N., Viodé, A., Wiedmer, A. E., Beerepoot, P., Chun, J. E., Glynn, C. A., Fernandes, A. R., et al. (2024) · Brain · doi:10.1093/brain/awad378 · Cited by 20 · see citing works

Suppressing UBE2N ameliorates Alzheimer's disease pathology through the clearance of amyloid beta

Zhang, C., Jia, Q., Zhu, L., Hou, J., Wang, X., Li, D., Zhang, J., Zhang, Y., Su, Y., Tu, Z., et al. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14122 · Cited by 19 · see citing works

Passive Immunotherapy Targeting Tau Oligomeric Strains Reverses Tauopathy Phenotypes in Aged Human-Tau Mice in a Mouse Model-Specific Manner

Bittar, A., Al-Lahham, R., Bhatt, N., Moore, K., Montalbano, M., Jerez, C., Fung, L., McAllen, S., Ellsworth, A., & Kayed, R. (2022) · Journal of Alzheimer's Disease · doi:10.3233/jad-220518 · Cited by 18 · see citing works

Involvement of heterologous ubiquitination including linear ubiquitination in Alzheimer’s disease and amyotrophic lateral sclerosis

Sato, Y., Terawaki, S., Oikawa, D., Shimizu, K., Okina, Y., Ito, H., & Tokunaga, F. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1089213 · Cited by 17 · see citing works

Traumatic brain injury derived pathological tau polymorphs induce the distinct propagation pattern and neuroinflammatory response in wild type mice

Puangmalai, N., Bhatt, N. N., Bittar, A., Jerez, C., Shchankin, N., & Kayed, R. (2023) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2023.102562 · Cited by 17 · see citing works

Molecular mechanisms implicated in protein changes in the Alzheimer’s disease human hippocampus

Nguyen, H. D., Kim, W.-K., & Vu, G. H. (2024) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2024.111930 · Cited by 17 · see citing works

The Involvement of Post-Translational Modifications in Regulating the Development and Progression of Alzheimer’s Disease

Guan, P.-P., & Wang, P. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03277-z · Cited by 15 · see citing works

Polymorphic Alpha-Synuclein Oligomers: Characterization and Differential Detection with Novel Corresponding Antibodies

Moore, K., Sengupta, U., Puangmalai, N., Bhatt, N. N., & Kayed, R. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03211-3 · Cited by 14 · see citing works

Internalization of extracellular Tau oligomers in Alzheimer’s disease

Chinnathambi, S., Rangappa, N., & Chandrashekar, M. (2025) · Advances in clinical chemistry · doi:10.1016/bs.acc.2025.01.005 · Cited by 14 · see citing works

Oligodendrocyte Dysfunction in Tauopathy: A Less Explored Area in Tau-Mediated Neurodegeneration

Majumder, M., & Dutta, D. (2024) · Cells · doi:10.3390/cells13131112 · Cited by 13 · see citing works

Excess Ub-K48 Induces Neuronal Apoptosis in Alzheimer’s Disease

Li, Q., Yuan, Y., Huang, S., Di, G., Chen, H., Zhuang, Y., Fang, W., Huang, Y., Tao, Y., Jiang, J., et al. (2024) · Journal of Integrative Neuroscience · doi:10.31083/j.jin2312223 · Cited by 12 · see citing works

Empagliflozin and memantine combination ameliorates cognitive impairment in scopolamine + heavy metal mixture-induced Alzheimer’s disease in rats: role of AMPK/mTOR, BDNF, BACE-1, neuroinflammation, and oxidative stress

Abdel-Lah, E. S., Sherkawy, H. S., Mohamed, W. H., Fawy, M. A., Hasan, A. A., Muhammed, A. A., Taha, A. F., Tony, A. A., Hamad, N., & Gamea, M. G. (2025) · Inflammopharmacology · doi:10.1007/s10787-025-01755-5 · Cited by 12 · see citing works

Calcineurin inhibition prevents synaptic plasticity deficit induced by brain-derived tau oligomers

Scaduto, P., Marcatti, M., Bhatt, N. N., Kayed, R., & Taglialatela, G. (2024) · Brain Communications · doi:10.1093/braincomms/fcae277 · Cited by 11 · see citing works

The interactome of tau phosphorylated at T217 in Alzheimer’s disease human brain tissue

Kavanagh, T., Thierry, M., Balcomb, K., Ponce, J., Kanshin, E., Tapia-Sealey, A., Halliday, G. M., Ueberheide, B. M., Wısnıewskı, T., & Drummond, E. (2025) · Acta Neuropathologica · doi:10.1007/s00401-025-02881-8 · Cited by 10 · see citing works

Targeting tau in Alzheimer’s Disease: rationale, approach and challenges

Aslanyan, A., Foiani, M. S., Giovannucci, T. A., McDade, E., Duff, K., Mummery, C. J., Schöll, M., Wildsmith, K. R., & Paterson, R. W. (2026) · Molecular Neurodegeneration · doi:10.1186/s13024-026-00925-5 · Cited by 10 · see citing works

Effect of Natural Osmolytes on Recombinant Tau Monomer: Propensity of Oligomerization and Aggregation

Arar, S. H., Haque, M. A., Bhatt, N. N., Zhao, Y., & Kayed, R. (2024) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00614 · Cited by 9 · see citing works

Some Nutritional Value Aspects of Barley and Oat and Their Impact in Human Nutrition and Healthy Life

Rusu, D. B., Murariu, D., Gheorghita, R. E., & Graur, M. (2024) · Plants · doi:10.3390/plants13192764 · Cited by 7 · see citing works

Comprehensive review on Alzheimer's disease: From the posttranslational modifications of Tau to corresponding treatments

Li, X., Ba, Z., Huang, J., Chen, J., Jiang, J., Huang, N., & Luo, Y. (2024) · Ibrain · doi:10.1002/ibra.12176 · Cited by 7 · see citing works

Tau Oligomers as Pathogenic Seeds: Preparation, Characterization, and Propagation In Vitro and In Vivo

Sengupta, U., & Kayed, R. (2024) · Methods in molecular biology · doi:10.1007/978-1-0716-3629-9_9 · Cited by 7 · see citing works

A brain‐derived tau oligomer polymorph is associated with cognitive resilience to Alzheimer's disease

Marcatti, M., Tumurbaatar, B., Zhang, W. R., Scaduto, P., Guptarak, J., Kadamangudi, S., Schuetze, R., Fracassi, A., Kayed, R., & Taglialatela, G. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70550 · Cited by 6 · see citing works

Untangling the Complexity and Impact of Tau Protein Ubiquitination

Trivellato, D., Munari, F., Assfalg, M., Capaldi, S., & D’Onofrio, M. (2024) · ChemBioChem · doi:10.1002/cbic.202400566 · Cited by 6 · see citing works

Post‐translational modifications linked to preclinical Alzheimer's disease–related pathological and cognitive changes

Abiose, O., Rutledge, J., Losada, P. M., Belloy, M. E., Wilson, E. N., He, Z., Trelle, A. N., Channappa, D., Romero, A., Park, J., et al. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.13576 · Cited by 6 · see citing works

C9orf72-associated dipeptide protein repeats form A11-positive oligomers in amyotrophic lateral sclerosis and frontotemporal dementia

Bhatt, N. N., Puangmalai, N., Sengupta, U., Jerez, C., Kidd, M., Gandhi, S. S., & Kayed, R. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.105628 · Cited by 5 · see citing works

Bioinformatic Analysis and Experimental Validation of Ubiquitin-Proteasomal System-Related Hub Genes as Novel Biomarkers for Alzheimer's Disease

Zhang, Y., Wu, J., You, G., Guo, W., Wang, Y., Yu, Z., Geng, Y., Zhong, Q., Zan, J., & Zheng, L. (2023) · Journal of Integrative Neuroscience · doi:10.31083/j.jin2206138 · Cited by 4 · see citing works

Inhibition of UBE2N promotes the clearance of mutant HTT (huntingtin) in HD knock-in mice

Ou, K., Wang, X., Guo, M., Li, D., Zhang, C., Chen, L., Hou, J., Jia, Q., Zhu, L., Yang, S., et al. (2025) · Autophagy · doi:10.1080/15548627.2025.2549109 · Cited by 3 · see citing works

Recent molecular insights and biosensor-based diagnostic technologies for hyperphosphorylated Tau in Alzheimer's disease

Shabana, S., Hamouda, H. I., Shang, A., Shao, S., Zhao, J., Yuan, H., & Liu, B. (2025) · Alzheimer s Research & Therapy · doi:10.1186/s13195-025-01932-2 · Cited by 3 · see citing works

Post-translational modifications as a regulatory code for tau function in health and disease

Nordbeck, A. J., Sharma, B., Garcia, C. A., & Tseng, J. (2026) · Frontiers in Dementia · doi:10.3389/frdem.2026.1834737 · Cited by 3 · see citing works

UBE3A: Bridging the gap between neurodevelopment, neural function, and neurodegenerative woes

Nash, K. R., Jinwal, U. K., & Bhat, K. M. (2024) · Journal of Alzheimer s Disease · doi:10.1177/13872877241283680 · Cited by 3 · see citing works

Morphological and Hyperphosphorylation Transitions of Nanoscale Tau Aggregates in Alzheimer's Disease

Santiago-Ruiz, A. N., Hugelier, S., Correa, G. L., Bond, C., Lee, E. B., & Lakadamyali, M. (2025) · Advanced Science · doi:10.1002/advs.202509773 · Cited by 3 · see citing works

Stage-dependent tau post-translational modifications map the spatiotemporal progression of Alzheimer’s diseasePreprint

Vanparys, A., Balty, C., Johanns, M., Zola, N. K. N., Herinckx, G., Calsteren, M. V., Suelves, N., Woodard, J. L., Vertommen, D., Kienlen‐Campard, P., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.04.10.717615 · Cited by 3 · see citing works

Characterization of conformation-specific antibodies TOMA-1 and TTCM-1 for recombinant tau monomer and amplified brain derived tau oligomer

Haque, M. A., Montalbano, M., Khan, S., Puangmalai, N., Bhatt, N. N., Shchankin, N., Jerez, C., & Kayed, R. (2025) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2025.167995 · Cited by 2 · see citing works

Molecular and environmental drivers of tau post-translational modifications and tau pathology

Price, T. M., Tucker, A. E., & Funk, K. E. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103223 · Cited by 2 · see citing works

Tau Oligomers in Alzheimer’s Disease: Modulation Effect of Osmolytes on Amplified Brain-Derived Tau Oligomers

Arar, S. H., Haque, M. A., Kayed, A., Khan, S., Bhatt, N. N., Zhao, Y., & Kayed, R. (2025) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5c00122 · Cited by 1 · see citing works

Interacting partners of Tau protein in Alzheimer’s disease

Chinnathambi, S., Velmurugan, G., Kumarappan, M., & Chandrashekar, M. (2025) · Advances in clinical chemistry · doi:10.1016/bs.acc.2025.10.005 · Cited by 1 · see citing works

Ubiquitin signatures on aggregating proteins in neurodegeneration

Sahoo, S., Padhy, A. A., Shivani, K., Misra, A., & Mishra, P. (2025) · Essays in Biochemistry · doi:10.1042/ebc20253046 · Cited by 1 · see citing works

Wild-type human α-synuclein induces progressive tau pathology in a disease-relevant mouse model of synucleinopathy

Senapati, S., Sciortino, A., Samples, M., Shchankin, N., Aday, A., Zhao, Y., Montalbano, M., & Kayed, R. (2026) · Molecular Neurodegeneration Advances · doi:10.1186/s44477-026-00033-0 · Cited by 1 · see citing works

Tau profiling of brain extracellular vesicles reveals PHF6 peptide as core for pathological tau seeding in Alzheimer's disease

Oosterlynck, M., Fichter, L., Leroux, É., Eddarkaoui, S., Bouillet, T., Lefebvre, C., Nguyen, M., Maurage, C., Accart, B., Dupré, E., et al. (2026) · Journal of Biomedical Science · doi:10.1186/s12929-026-01250-1 · Cited by 1 · see citing works

Ubiquitin Signaling to NF-κB

Soto‐Díaz, K., Varfolomeev, E. E., & Vucic, D. (2025) · Elsevier eBooks · doi:10.1016/b978-0-12-824465-4.00198-8

Regional correlates of tau pathology and synaptic function in primary age-related tauopathy

Kadamangudi, S., Sánchez-Sánchez, L., Limón, A., & Taglialatela, G. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877261416524

Analysis of the Genetic Comorbid Mechanisms of Type 2 Diabetes, Alzheimer′s Disease, and Hypertension Using Network Modularization

Tian, S., Zong, W., Zeng, Z., Wang, J., Niu, Q., Zhang, S., Zhang, H., & Li, B. (2026) · BioMed Research International · doi:10.1155/bmri/8877510

Caractérisation des mécanismes moléculaires impliqués dans la mise en place des altérations cérébrales dans un modèle préclinique de diabète de type 2

Hamzé, R. (2023) · theses.fr (ABES) · doi:10.70675/3ac7f72cz196fz4796z99a3z89271cd76677

Tracking Tau Multimerization in the Adult Drosophila Brain

Chinchankar, M. N., & Frost, B. E. (2026) · Neuromethods · doi:10.1007/978-1-0716-5234-3_14

Disease-specific tau polymorphs are associated with unique protein networks across proteinopathies

Puangmalai, N., Bhatt, N. N., Suthprasertporn, N., Miranda-Morales, E. G., Shchankin, N., Samples, M., Balci, A. E., Liew, J. Y., Montalbano, M., Zhao, Y., et al. (2026) · The EMBO Journal · doi:10.1038/s44318-026-00897-8

The Function of Tau in Astrocytes: Advantage or Damage

Luis-Hernández, K. G., Beltrán‐Parrazal, L., Morgado‐Valle, C., López‐Meraz, M. L., García, L. I., & Chi-Castañeda, D. (2026) · Neuroglia · doi:10.3390/neuroglia7030030

From seeds to symptoms: the molecular landscape of tau seeding in Alzheimer’s disease

Miao, J., Xue, C., Yan, X., Gu, J., Chu, D., & Sun, H. (2026) · Frontiers in Neuroscience · doi:10.3389/fnins.2026.1927017

Conformation-specific anti-pathological tau antibody raised against AD brain-derived seed-competent tau reduces tau pathology in transgenic mice

Yanamandra, K., Romanul, N., Patel, H., Sanders, H., Chang, R., Darcy, A., Brown, N., Kane, C. A., Wu, H.-Y., Jagtap, K., et al. (2026) · Molecular Neurodegeneration Advances · doi:10.1186/s44477-026-00049-6

Protein Quality Control Systems in Neurodegeneration—Chaperones, Cytoskeleton, and the Pathogenic Transition of Tau

Bisht, A., Pippadpally, S., & Kumar, V. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-06310-z

Sequestosome 1/p62 shuttles polyubiquitinated tau for proteasomal degradation

Babu, J. R., Geetha, T., & Wooten, M. W. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03181.x · Cited by 315 · see citing works

Serine-65 phosphorylated ubiquitin associates with soluble tau and seeding activity in Alzheimer’s disease

Yan, T., Hou, X., Watzlawik, J. O., Dickson, D. W., Fiesel, F. C., & Springer, W. (2026) · Nature Communications · doi:10.1038/s41467-026-78418-8

Polyubiquitination of Tau Increases Across Braak Stages in Alzheimer’s Disease

Lee, Y. B., Kramer, J., Oh, I. M., Li, S. H., Piergies, A. M. H., Xue, J., Kumar, M., Spina, S., Steen, J. A. J., & Grinberg, L. T. (2022) · Alzheimer s & Dementia · doi:10.1002/alz.066600

Identification of linear polyubiquitin chain immunoreactivity in tau pathology of Alzheimer’s disease

Nakayama, Y., Sakamoto, S., Tsuji, K., Ayaki, T., Tokunaga, F., & Ito, H. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2019.03.017 · Cited by 24 · see citing works

Tau interactome mapping based identification of Otub1 as Tau deubiquitinase involved in accumulation of pathological Tau forms in vitro and in vivo

Wang, P., Joberty, G., Buist, A., Vanoosthuyse, A., Stancu, I., Vasconcelos, B., Pierrot, N., Faelth-Savitski, M., Kienlen‐Campard, P., Octave, J., et al. (2017) · Acta Neuropathologica · doi:10.1007/s00401-016-1663-9 · Cited by 118 · see citing works